ANIK ANIKA THERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 4 analyst firms say about ANIKA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
2 rated views · 4 analyst/firm records · 4 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
Recent analyst activity · last 90 days
Our tracked history has 3 reports on ANIK from 3 analyst firms in the last 90 days (4 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target.
No firm's latest available rating differs from its previous one.
Latest observed target change: B. Riley Financial raised its target from $21.00 (set 30 Jul 2026) to $23.00 on 18 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Madison El-Saadi | Buy | 18 Sep 2026 | 23.00 USD |
| Barrington Research | Michael J Petusky | ConflictConflicting reports · excluded | 30 Jul 2026 | 21.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 28 Sep 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:05 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.